Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Evaluating Plasma Exposure of Optimized Antibiotic Therapy According to TDM in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

NCT04132115 is registered in ClinicalTrials.gov with Azienda Sanitaria-Universitaria Integrata di Udine as lead sponsor.

NCT NCT04132115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04132115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Evaluating Plasma Exposure of Optimized Antibiotic Therapy According to TDM in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
Lead sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2019
Completion date
October 31, 2021
Enrollment
104 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage, subarachnoid hemorrhage, therapeutic drug monitoring